Cantargia AB logo

CANTA BTA - Cantargia AB News Story

SEK7.34 0.0  0.0%

Last Trade - 11/01/18

Sector
Healthcare
Size
Small Cap
Market Cap £186.6m
Enterprise Value £143.1m
Revenue £n/a
Position in Universe th / 1782

BRIEF-Cantargia Submits Ind Application For Can04

Tue 7th April, 2020 3:02pm
April 7 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA SUBMITS IND APPLICATION FOR CAN04
    * CANTARGIA AB - APPLICATION FOR A US IND REGARDING ANTIBODY CAN04 HAS BEEN SUBMITTED TO US
FDA
    * CANTARGIA AB - IS NOW IN PROCESS OF BROADENING DEVELOPMENT ACTIVITIES AND NEXT STEP IS A
PHASE
IB TRIAL INVESTIGATING CAN04 IN COMBINATION WITH PEMBROLIZUMAB (KEYTRUDA(®))

Source text for Eikon:  ID:nWkr5bwgYM 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.